U.S. flag

An official website of the United States government

Format

Send to:

Choose Destination
    • Showing Current items.

    GPC6 glypican 6 [ Homo sapiens (human) ]

    Gene ID: 10082, updated on 2-Nov-2024

    GeneRIFs: Gene References Into Functions

    GeneRIFPubMed TitleDate
    Five siblings expand the spectrum of GPC6-related skeletal dysplasia.

    Five siblings expand the spectrum of GPC6-related skeletal dysplasia.
    Crenshaw MM, Meyers ML, Brown K, Slegesky V, Duis J, Elias ER, Saenz M, Shi W, Filmus J, Meeks NJL.

    09/23/2023
    Prognostic value of GPC5 polymorphism rs2352028 and clinical characteristics in Chinese lung cancer patients.

    Prognostic value of GPC5 polymorphism rs2352028 and clinical characteristics in Chinese lung cancer patients.
    Wang F, Li Y, Li Z, Zou Z, Lu Y, Xu C, Zhao Z, Wang H, Wang Y, Guo S, Jin L, Wang J, Li Q, Jiang G, Xia F, Shen B, Wu J.

    10/22/2022
    TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6.

    TDP-43 proteinopathy alters the ribosome association of multiple mRNAs including the glypican Dally-like protein (Dlp)/GPC6.
    Lehmkuhl EM, Loganathan S, Alsop E, Blythe AD, Kovalik T, Mortimore NP, Barrameda D, Kueth C, Eck RJ, Siddegowda BB, Joardar A, Ball H, Macias ME, Bowser R, Van Keuren-Jensen K, Zarnescu DC., Free PMC Article

    11/13/2021
    Can Glypican-6 Level Predict Ejection Fraction Decline After Myocardial Infarction?

    Can Glypican-6 Level Predict Ejection Fraction Decline After Myocardial Infarction?
    Ozturk F, Atici A, Barman HA.

    06/26/2021
    Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial-mesenchymal transition of gastric cancer cells.

    Hedgehog signaling activation required for glypican-6-mediated regulation of invasion, migration, and epithelial-mesenchymal transition of gastric cancer cells.
    Zeng C, Yan R, Yang G, Xiang S, Zhao F., Free PMC Article

    03/27/2021
    GPC6 rs4773724 was associated with a decreased risk of LDH in allele model (OR = 0.82, 95% CI: 0.68-0.98, p = 0.026), whereas rs1008993 increased the LDH risk (OR = 1.34, 95% CI: 1.05-1.71, p = 0.020). rs4773724 and rs9523981 were associated with susceptibility of LDH among individuals whose age are less than 45. And rs1008993 was associated with increased LDH risk in males.

    Association of glypican-6 polymorphisms with lumbar disk herniation risk in the Han Chinese population.
    Hu B, Xing W, Li F, Huang Z, Zheng W, Ji D, Niu F, Zhu Y, Yang X., Free PMC Article

    07/18/2020
    findings identified GPC6 as an early biomarker for melanoma metastatic progression, one that can be regulated by miR-509-3p.

    Glypican 6 is a putative biomarker for metastatic progression of cutaneous melanoma.
    Li Y, Li M, Shats I, Krahn JM, Flake GP, Umbach DM, Li X, Li L., Free PMC Article

    02/15/2020
    Thus, GPC6 and TMEM132D may serve as predictors of CD8+ T-lymphocyte infiltration and as favorable prognostic markers in early stage ovarian cancer with important consequences for diagnosis.

    Overexpression of GPC6 and TMEM132D in Early Stage Ovarian Cancer Correlates with CD8+ T-Lymphocyte Infiltration and Increased Patient Survival.
    Karapetsas A, Giannakakis A, Dangaj D, Lanitis E, Kynigopoulos S, Lambropoulou M, Tanyi JL, Galanis A, Kakolyris S, Trypsianis G, Coukos G, Sandaltzopoulos R., Free PMC Article

    07/30/2016
    Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.

    Extracellular matrix proteins expression profiling in chemoresistant variants of the A2780 ovarian cancer cell line.
    Januchowski R, Zawierucha P, Ruciński M, Nowicki M, Zabel M., Free PMC Article

    02/14/2015
    GPC6 promotes invasive migration by inhibition of canonical beta-catenin and Wnt signalling, and up-regulation of non-canonical Wnt5A signalling leading to the activation of JNK and p38 MAPK.

    NFAT promotes carcinoma invasive migration through glypican-6.
    Yiu GK, Kaunisto A, Chin YR, Toker A., Free PMC Article

    12/24/2011
    Observational study and genome-wide association study of gene-disease association. (HuGE Navigator)

    A genome-wide association study of neuroticism in a population-based sample.
    Calboli FC, Tozzi F, Galwey NW, Antoniades A, Mooser V, Preisig M, Vollenweider P, Waterworth D, Waeber G, Johnson MR, Muglia P, Balding DJ., Free PMC Article

    09/15/2010
    Clinical trial of gene-disease association and gene-environment interaction. (HuGE Navigator)

    Personalized smoking cessation: interactions between nicotine dose, dependence and quit-success genotype score.
    Rose JE, Behm FM, Drgon T, Johnson C, Uhl GR., Free PMC Article

    06/30/2010
    a reduction in GPC6 mRNA in retinoblastoma is associated with the non-random allelic loss at 13q31 that could contribute to RB development.

    Allelic imbalance at 13q31 is associated with reduced GPC6 in Chinese with sporadic retinoblastoma.
    Lau CS, Yu CB, Wong HK, Fan DS, Mak HT, Wong KW, Lam DS, Pang CP, Choy KW.

    05/31/2010
    Observational study of gene-disease association. (HuGE Navigator)See all PubMed (2) articles

    Association to the Glypican-5 gene in multiple sclerosis.
    Lorentzen AR, Melum E, Ellinghaus E, Smestad C, Mero IL, Aarseth JH, Myhr KM, Celius EG, Lie BA, Karlsen TH, Franke A, Harbo HF.

    Sequential use of transcriptional profiling, expression quantitative trait mapping, and gene association implicates MMP20 in human kidney aging.
    Wheeler HE, Metter EJ, Tanaka T, Absher D, Higgins J, Zahn JM, Wilhelmy J, Davis RW, Singleton A, Myers RM, Ferrucci L, Kim SK.

    12/2/2009
    Mutations in the heparan-sulfate proteoglycan glypican 6 impair endochondral ossification and cause recessive omodysplasia

    Mutations in the heparan-sulfate proteoglycan glypican 6 (GPC6) impair endochondral ossification and cause recessive omodysplasia.
    Campos-Xavier AB, Martinet D, Bateman J, Belluoccio D, Rowley L, Tan TY, Baxová A, Gustavson KH, Borochowitz ZU, Innes AM, Unger S, Beckmann JS, Mittaz L, Ballhausen D, Superti-Furga A, Savarirayan R, Bonafé L., Free PMC Article

    01/21/2010
    firstprevious page of 1 nextlast